Casalenuovo Lisa DO is categorized under Internal Medicine Doctors in Parkersburg, WV and active since 2008.
Casalenuovo Lisa DO was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Lisa Casalenuovo at the company’s single location by writing to 801 Garfield Avenue # 200, Parkersburg, West Virginia WV 26101 or by phoning (304) 424-2165. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Casalenuovo Lisa DO |
| Contact Person: | Lisa Casalenuovo |
| Address: | 801 Garfield Avenue # 200, Parkersburg, West Virginia 26101 |
| Phone Number: | (304) 424-2165 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Casalenuovo Lisa DO was started in 2008 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Lisa Casalenuovo for inquiries that concern Casalenuovo Lisa DO by calling the company number (304) 424-2165, as your correspondence is most welcome. Additionally, the physical location of the single location of Casalenuovo Lisa DO can be found at the coordinates 39.2702,-81.56036 as well as the street address 801 Garfield Avenue # 200 in Parkersburg, West Virginia 26101.
For its online presence, you may visit Casalenuovo Lisa DO’s website at and engage with its social media outlets through on Twitter and on Facebook.